High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

about

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

Item

http://www.wikidata.org/entity/Q36551196

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

@ast

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

@en

type

Item

label

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

@ast

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

@en

prefLabel

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

@ast

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

@en

P1476

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

@en

P2093

Jin-Wei Miao

http://www.w3.org/2001/XMLSchema#string

Xiao-Hong Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant radiotherapy for stage I endometrial cancer

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.

Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer

Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.

The role of radiotherapy in endometrial cancer: current evidence and trends

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.

Chemotherapy plus radiation in advanced-stage endometrial cancer.

P304

332-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.1000-9604.2012.10.03

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23359621

http://www.w3.org/2001/XMLSchema#string

P932

3551334

http://www.w3.org/2001/XMLSchema#string